银屑病关节炎患者与类风湿关节炎患者相比诊断延迟且治疗强度较低:一项嵌套于英格兰和威尔士审计数据集的研究
本研究基于2018年5月至2019年10月31日国家早期炎症性关节炎审计数据,将2120例银屑病关节炎患者与类风湿关节炎患者按年龄和性别1:1匹配,其中1250例为多关节型。结果显示银屑病关节炎患者转诊前症状持续时间更长,从全科医生就诊到诊断时间更长(平均112天 vs 89天;HR 0.87;95%CI 0.79-0.96;P=0.007),且多关节型患者基线改善病情抗风湿药处方比例更低(54.0% vs 69.0%;P<0.001),3个月时疾病活动度平均评分高出0.27(95%CI 0.13-0.4),提示治疗不足。
要点
- 银屑病关节炎患者从全科医生就诊到诊断时间显著长于类风湿关节炎患者(平均112天 vs 89天;HR 0.87)。
- 多关节型银屑病关节炎患者基线改善病情抗风湿药处方比例低于类风湿关节炎患者(54.0% vs 69.0%;P<0.001)。
- 3个月时银屑病关节炎患者疾病活动度平均评分较类风湿关节炎患者高0.27(95%CI 0.13-0.4),提示治疗不足。
核心结论
- 与类风湿关节炎患者相比,银屑病关节炎患者转诊前症状持续时间更长,从全科医生就诊到获得诊断的间隔更长。
- 多数人同意达标治疗策略,但银屑病关节炎患者起始改善病情抗风湿药少于类风湿关节炎患者,且3个月时疾病活动度改善更低,提示治疗不足。
研究设计与样本
- 研究嵌套于国家早期炎症性关节炎审计数据集,纳入2018年5月至2019年10月31日期间的患者。
- 共2120例银屑病关节炎患者按年龄和性别1:1匹配类风湿关节炎患者,其中1250例为多关节型。
- 比较两组患者特征、诊断时间,并进一步限制于多关节型银屑病关节炎匹配对,比较疾病活动度、疾病影响和治疗起始。
主要发现
- 银屑病关节炎患者转诊前症状持续时间长于类风湿关节炎患者。
- 银屑病关节炎患者从全科医生就诊到诊断时间更长(平均112天 vs 89天;HR 0.87;95%CI 0.79-0.96;P=0.007)。
- 转诊至二级保健后诊断延迟(HR 0.86;95%CI 0.80-0.95;P=0.002)。
- 多关节型患者基线改善病情抗风湿药处方比例银屑病关节炎组为54.0%,类风湿关节炎组为69.0%(P<0.001)。
- 类风湿关节炎患者基线28关节疾病活动度评分更高,但3个月时银屑病关节炎患者平均评分高0.27(95%CI 0.13-0.4)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: This study aimed to compare time to diagnosis among patients with psoriatic arthritis (PsA) with that of patients with rheumatoid arthritis (RA) and compare initial treatment and outcomes. METHODS: Patients with PsA were identified from the National Early Inflammatory Arthritis Audit between May 2018 and October 31, 2019, and matched to patients with RA (1:1) on age and sex. Patient characteristics and time to diagnosis were compared between PsA and RA groups. Further comparisons were made, restricted to matched pairs of patients with polyarticular PsA, including disease activity, disease impact, and treatment initiation. RESULTS: In total, 2120 patients with PsA were matched to patients with RA, of which 1250 had polyarticular disease. Symptom duration before referral was longer in patients with PsA than that in patients with RA. Patients with PsA had a longer time from general practitioner (GP) presentation to diagnosis (mean, 112 v 89 days; hazard ratio [HR], 0.87; 95% CI, 0.79-0.96; P = .007), including a delay in diagnosis once referrals were received in secondary care (HR, 0.86; 95% CI, 0.80-0.95; P = .002). In patients with polyarticular disease, less disease-modifying antirheumatic drugs (DMARDs) were prescribed at baseline to patients with PsA compared with those to patients with RA (54.0% and 69.0%, respectively; P < .001). Patients with RA had a higher Disease Activity Score in 28 joints at baseline, but by 3 months, the average score was 0.27 (95% CI, 0.13-0.4) higher in patients with PsA. CONCLUSIONS: Compared with patients with RA, patients with PsA have a longer duration of symptoms before referral and a longer interval between presentation to the GP and receiving a diagnosis. Most people agreed a treat-to-target strategy but fewer DMARDs were commenced for patients with PsA than those for patients with RA and a lower improvement in disease activity was achieved at 3 months, suggesting undertreatment.
引用
- Charlton RA, Gates E, Coates LC, et al. Diagnostic delay and less intensive therapy for people with psoriatic arthritis compared with rheumatoid arthritis: a study nested within an English and Welsh audit data set. Ann Rheum Dis. 2025. PMID: 40158947. doi:10.1016/j.ard.2025.02.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。